RELATED CONTENT Oral GLP-1s are set to shake up the weight-loss drug market, with Foundayo, launched by Eli Lilly in early April, already making waves across the U.S
We find that patients benefit from at least a 12-month comprehensive weight-loss program to establish the proper habits to sustain long-term weight loss If you are not a good candidate for GLP-1 agonists, our physicians will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools that we use as a part of our weight loss program in Agoura Hills, California
William Seeds: Thank you for having me
FINAL THOUGHTS Standard T2DM treatments including metformin and GLP-1 and GLP-1/GIP agonists exhibit metabolic, immunologic, and hormonal effects that should be explored in other disease contexts
Wondering if it's safe? Let's break it down